Editorial
| Rev Diabet Stud,
2004,
1(3):108-112 |
DOI 10.1900/RDS.2004.1.108 |
Immunotherapy After Recent-Onset Type 1 Diabetes: Combinatorial Treatment for Achieving Long-Term Remission in Humans?
Damien Bresson, Matthias von Herrath
La Jolla Institute for Allergy and Immunology, Department of Developmental Immunology 3, 10355 Science Center Drive, San Diego, California 92121, USA.
Address correspondence to: Matthias von Herrath, e-mail: matthias@liai.org
Keywords: immunotherapy, anti-CD3, antigen-specific intervention, recent-onset type 1 diabetes, regulatory T cells
Abstract
n/a
Fulltext:
 HTML
,  PDF
(230KB)
This article has been cited by other articles:
|
